Assessing the value of healthcare innovations: a proposal for an integrated health technology assessment-responsible innovation in health approach in the "new normal"

被引:3
作者
Mukherjee, Kanchan [1 ]
Walley, Tom [2 ]
机构
[1] Tata Inst Social Sci TISS, Sch Hlth Syst Studies, Ctr Hlth Policy Planning & Management, Mumbai, Maharashtra, India
[2] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool, Merseyside, England
关键词
Technology assessment; COVID-19; Innovation; Ecosystems; Healthcare systems; HTA; FRAMEWORK;
D O I
10.1017/S0266462322000319
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
There has been tremendous technological innovation in the healthcare sector, but it has also raised serious ethical and social concerns. The COVID-19 pandemic has only magnified these existing challenges. Hence, addressing these challenges becomes imperative in the "new normal." In this context, this article uses a narrative synthesis approach to discuss the linkages of health technology, innovation, and policy to identify the challenges of this complex interaction by applying the principles of pragmatism and historicity to the existing literature. Moreover, the existing scientific mechanisms in the form of health technology assessment (HTA) and responsible innovation in health (RIH) are described to address these challenges. Using inductive epistemology, the linkages between HTA and RIH within a health innovation ecosystem framework are discussed for the future application of an integrated approach to address societal challenges. The proposed integrated approach of HTA and RIH is a work in progress and conceptualized as transdisciplinary, flexible, and adaptive, which is expected to facilitate future discussion, research, and policy action.
引用
收藏
页数:5
相关论文
共 35 条
  • [1] The effect of spokesperson attribution on public health message sharing during the COVID-19 pandemic
    Abu-Akel, Ahmad
    Spitz, Andreas
    West, Robert
    [J]. PLOS ONE, 2021, 16 (02):
  • [2] Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)
    Agarwal, Anup
    Mukherjee, Aparna
    Kumar, Gunjan
    Chatterjee, Pranab
    Bhatnagar, Tarun
    Malhotra, Pankaj
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2020, 371
  • [3] [Anonymous], UNDP GLOBAL DASHBOAR
  • [4] HOW COVID IS CHANGING THE STUDY OF HUMAN BEHAVIOUR
    Aschwanden, Christie
    [J]. NATURE, 2021, 593 (7859) : 331 - 333
  • [5] History of HTA: Introduction
    Banta, David
    Jonsson, Egon
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2009, 25 : 1 - 6
  • [6] INTEGRATE-HTA: A LOW- AND MIDDLE-INCOME COUNTRY PERSPECTIVE
    Bijlmakers, Leon
    Mueller, Debjani
    Kahveci, Rabia
    Chen, Yingyao
    van der Wilt, Gert Jan
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2017, 33 (05) : 599 - 604
  • [7] Definitions and Conceptual Dimensions of Responsible Research and Innovation: A Literature Review
    Burget, Mirjam
    Bardone, Emanuele
    Pedaste, Margus
    [J]. SCIENCE AND ENGINEERING ETHICS, 2017, 23 (01) : 1 - 19
  • [8] Cutler DM, 2001, HEALTH AFFAIR, V20, P11
  • [9] Responsible research and innovation: a productive model for the future of medical innovation
    Demers-Payette, Olivier
    Lehoux, Pascale
    Daudelin, Genevieve
    [J]. JOURNAL OF RESPONSIBLE INNOVATION, 2016, 3 (03) : 188 - 208
  • [10] Innovation ecosystems: A conceptual review and a new definition
    Granstrand, Ove
    Holgersson, Marcus
    [J]. TECHNOVATION, 2020, 90-91